Go Back

AEBSF (Serine Protease Inhibitor)
$25.60 - $144.00
$180.00
AEBSF is a broad-spectrum, irreversible serine protease inhibitor that targets serine proteases in the signaling pathway. In vitro studies have shown that AEBSF directly inhibits β-secretase, reducing the production of Aβ components in various human cell lines. It also inhibits the lysis of leukemia cells by human macrophages without affecting the secretion of TNF-α and IL-1β. Additionally, AEBSF disrupts blastocyst growth in the uterine endometrium and hinders the adhesion of HeLa cells to HUVECs by altering protein secretion mechanisms. In vivo studies have demonstrated that AEBSF administration extends the survival of mice injected with Toxoplasma gondii and reduces respiratory reactions and potential inflammation in a cockroach-induced allergy model. No clinical trials have been reported for AEBSF. Overall, AEBSF exhibits characteristics of a broad-spectrum irreversible serine protease inhibitor.
Select
Quantity
Add to cart
More Details
All products have special prices for bulk purchase, please contact for more details if required.
Cat. No.: AEBSF-5 (for 5mg)
Cat. No.: AEBSF-25 (for 25mg)
Cat. No.: AEBSF-100 (for 100mg)
Chemical Information
- Chemical Name: 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride
- Abbreviation: AEBSF
- Synonyms: AEBSF HCL; PEFABLOC SC; 4-(2-Aminoethyl)ben
- Chemical Formula: C8H11ClFNO2S
- Molecular Weight: 239.69
- CAS Number: 30827-99-7
- Purity: 99%
- Solvent/Solubility: Water 48mg/ml; DMSO 48mg/ml; Ethanol 13mg/ml
- Solution Preparation: Dissolve 5mg in 2.086ml DMSO, or dissolve 2.40mg in 1ml DMSO to prepare a 10mM solution.
Biology Information
- Product Description: AEBSF is a broad-spectrum, irreversible serine protease inhibitor.
- Signaling Pathway: Proteases
- Target: Serine protease
- In Vitro Studies: AEBSF inhibits the production of Aβ components by directly inhibiting β-secretase in various human cell lines, including neuronal and non-neuronal cells. As a serine protease inhibitor, AEBSF inhibits the lysis of leukemia cells by human macrophages without inhibiting the secretion of TNF-α and IL-1β in macrophages. AEBSF also disrupts the growth of blastocysts in the uterine endometrium and inhibits the adhesion of HeLa cells to HUVECs by altering protein secretion mechanisms.
- In Vivo Studies: AEBSF (76.8 mg/kg per day, intraperitoneal injection) extends the survival of mice with lethal injection of Toxoplasma gondii. AEBSF also reduces respiratory reactions and potential inflammation in a mouse model of cockroach-induced allergy.
- Clinical Trials: N/A
- Characteristics: Broad-spectrum irreversible serine protease inhibitor.
Precautions
- This product is for scientific research purposes only and is intended for use by professionals. It is not to be used for clinical diagnosis or treatment, and should not be used in food or drugs. It should not be stored in residential areas.
- For your safety and health, please wear laboratory attire and disposable gloves when handling this product.
Storage
Store at room temperature, valid for at least 6 months. If dissolved in a non-DMSO solvent, it is recommended to aliquot and store at -80°C, expected to be valid for up to 6 months.
Only for research and not intended for treatment of humans or animals
Journals Using SBS Genetech Products Universities Using SBS Genetech Products
SBS Genetech is a long-term sponsor of Cold Spring Harbor Laboratory